Dominican Republic vs Tuvalu: Prevalence of hypertension, female
Dominican Republic
49.2%
in 2019
Tuvalu
50.8%
in 2019
Dominican Republic rank
4th
Tuvalu rank
2nd
Prevalence of hypertension, female over time
- Dominican Republic
- Tuvalu
How they compare
Tuvalu currently reports 50.8% against 49.2% in Dominican Republic, a difference of 1.6%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Dominican Republic ahead.
Dominican Republic ranks 4th and Tuvalu ranks 2nd of 192 countries.
Dominican Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 43.3% | 37.9% | 5.3% | Dominican Republic |
| 2000s | 46.3% | 40.1% | 6.2% | Dominican Republic |
| 2010s | 48.9% | 47.4% | 1.4% | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, female, Dominican Republic or Tuvalu?
- Tuvalu, at 50.8% against 49.2% in Dominican Republic as of 2019.
- What is the difference in prevalence of hypertension, female between Dominican Republic and Tuvalu?
- 1.6%, with Tuvalu ahead.
- How many years of comparable data are there for Dominican Republic and Tuvalu?
- 30 years are reported by both, from 1990 to 2019.
- How do Dominican Republic and Tuvalu rank globally for prevalence of hypertension, female?
- Dominican Republic ranks 4th and Tuvalu ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, female (% of female adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, female, is the percentage of female adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.